Empowering Clinical Decisions · Leading Precision Health
PANACEA specializes in precision decoding of the immune microenvironment. Driven by our core ImmunAI Analysis System, we combine high-dimensional flow cytometry with LLM technology, supervised by Ph.D. experts in immunology.
We transform complex flow cytometry data into intuitive, actionable summaries for physicians, enhancing clinical decision speed and diagnostic precision.
Current findings indicate "Transient Immune Remodeling" post-surgery. However, elevated Exhausted Tc cells and low Treg suggest a weakened anti-inflammatory mechanism, increasing the risk of chronic inflammation.
Beyond simple cell counts, we use Big Data Normalization Models to map the immune landscape.
Precise monitoring of T-cell differentiation (Th1/Th2/Th17/Treg), NK subsets, and DCs to identify early signs of Immunosenescence.
AI algorithms evaluate tumor microenvironment correlation, latent infection trends, and Autoimmune Tolerance indices.
Providing scientific suitability scoring for mainstream cell therapies (MSC, NK, DC) to assist institutions in pre-treatment screening.
Compliant, Rigorous, International Lab Standards
Clinical evaluation by partnering physicians.
4.5 mL whole blood with cold chain logistics.
Ph.D. review + Double LLM AI Analysis.
Report delivery and clinical debriefing in ~7 days.
Contact our consultants to request sample reports or discuss B2B partnership programs for medical institutions.